Loading...
XASX
MPL
Market cap9.04bUSD
Jul 10, Last price  
5.08AUD
1D
0.00%
1Q
11.56%
Jan 2017
78.01%
IPO
139.05%
Name

Medibank Private Ltd

Chart & Performance

D1W1MN
P/E
28.41
P/S
1.74
EPS
0.18
Div Yield, %
3.31%
Shrs. gr., 5y
—
Rev. gr., 5y
3.46%
Revenues
8.02b
+7.48%
6,005,000,0006,485,700,0006,681,600,0006,807,400,0006,948,100,0006,576,900,0006,765,000,0006,832,400,0006,984,400,0007,197,700,0007,460,100,0008,018,300,000
Net income
493m
-3.64%
232,700,000130,800,000285,300,000417,600,000449,500,000445,100,000458,700,000315,000,000441,200,000393,900,000511,100,000492,500,000
CFO
869m
+236.37%
104,501,000312,800,000377,100,000352,300,000393,400,000408,300,000416,100,000600,200,000498,200,000962,700,000258,200,000868,500,000
Dividend
Sep 04, 20240.094 AUD/sh
Earnings
Aug 19, 2025

Profile

Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. The company underwrites its health insurance products under the Medibank and ahm brands Medibank Private Limited was founded in 1976 and is based in Docklands, Australia.
URL
https://www.medibank.com.au
IPO date
Nov 25, 2014
Employees
3,242
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
8,018,300
7.48%
7,460,100
3.65%
Cost of revenue
926,800
303,400
Unusual Expense (Income)
NOPBT
7,091,500
7,156,700
NOPBT Margin
88.44%
95.93%
Operating Taxes
215,300
216,000
Tax Rate
3.04%
3.02%
NOPAT
6,876,200
6,940,700
Net income
492,500
-3.64%
511,100
29.75%
Dividends
(426,900)
(374,500)
Dividend yield
4.16%
3.86%
Proceeds from repurchase of equity
(7,500)
(4,900)
BB yield
0.07%
0.05%
Debt
Debt current
66,600
30,900
Long-term debt
335,100
48,800
Deferred revenue
Other long-term liabilities
2,228,600
972,800
Net debt
(3,396,200)
(3,325,300)
Cash flow
Cash from operating activities
868,500
258,200
CAPEX
(7,000)
(41,900)
Cash from investing activities
(110,800)
(15,200)
Cash from financing activities
(487,300)
(419,100)
FCF
4,592,300
7,014,000
Balance
Cash
927,900
420,600
Long term investments
2,870,000
2,984,400
Excess cash
3,396,985
3,031,995
Stockholders' equity
2,305,100
2,084,400
Invested Capital
2,107,000
754,200
ROIC
480.65%
829.19%
ROCE
160.73%
252.12%
EV
Common stock shares outstanding
2,754,003
2,754,003
Price
3.73
5.97%
3.52
8.31%
Market cap
10,272,432
5.97%
9,694,091
8.31%
EV
6,875,632
6,368,791
EBITDA
7,180,900
7,236,200
EV/EBITDA
0.96
0.88
Interest
5,400
1,800
Interest/NOPBT
0.08%
0.03%